Work

Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis

Year: 2015
Type: article
Abstract: Meeting abstracts Adoptive transfer of chimeric antigen receptor (CAR)-engineered T cells has demonstrated robust and durable clinical efficacy in patients with CD19+ B cell malignancies. Broader application of this approach to brain and other advanced solid tumors is an immediate goal for the
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2218918403
FWCI:
Cites:
Cited by: 3
Related to: 10